- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Nanostart subsidiary Nanostart Asia Pte Ltd now has its own web presence. The new independent website reflects the expanding business of this Nanostart subsidiary.
Virtually every target group can find relevant information within only a few clicks of the homepage. Users have the opportunity to learn about the structure of the Nanostart Singapore Early Stage Venture Fund, which is managed by Nanostart Asia. Shareholdings held by the fund are also profiled. Nanotechnology companies that are seeking capital can examine Nanostart investment criteria and utilize a checklist to evaluate their chances for cooperation. The website also features profiles of Nanostart Asia contact persons, who are available to answer questions. The design of the new Nanostart Asia website reflects the relationship with Nanostart AG, while simultaneously demonstrating the independence of the Asian location. The site serves primarily as a source of information for users in Asia. All content is therefore available only in English.
Nanostart Asia was launched in 2008. Shareholdings in three companies are currently held through the Singapore Early Stage Venture Fund, which is managed by Nanostart Asia.
Andreas Kröll, managing director of Nanostart Asia, explained that the decision to invest in nanotechnology in Singapore is due to the outstanding research landscape and the excellent support of the government, as the shared financing of the fund with the National Research Foundation demonstrates. Singapore is the basis for Nanostart's business in Asia.
Users may visit the Nanostart Asia website at www.nanostart-asia.com.
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the "Entry Standard" segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within Canada, Australia, or Japan.
About Nanostart AG
Nanostart AG, headquartered in the German financial capital of Frankfurt, is the world’s leading nanotechnology investment company, with portfolio companies spanning the globe from Silicon Valley to Singapore. The company provides venture capital financing for nanotechnology companies in various growth phases with a focus on innovation-driven industries of the future such as cleantech, life sciences, and IT/electronics. Through its subsidiary and venture capital fund in Singapore, Nanostart is proud to be the investment partner of the Singaporean government.
For further information about the company, please visit www.nanostart.de.
For more information, please click here
Dr. Hans Joachim Dürr
Public Relations Manager
phone: +49 69 219396 111
fax: +49 69 219396 122
Copyright © Nanostart AGIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Blue Star Opportunities Corp. (BSTO) Completes Major Condo Building Project in Manhattan Residential Area; Company Now Has the Resources to Service the Largest of Construction Projects April 21st, 2015
DFG to Establish One Clinical Research Unit and Five Research Units: New Projects to Investigate Complications in Pregnancy, Particle Physics, Nanoparticles, Implants and Transport Planning / Approximately 13 Million Euros in Funding for an Initial Three-Year Period March 28th, 2015
Haydale Announce Dedicated Graphene Inks Manufacturing Capability March 25th, 2015
LamdaGen Corporation Launches Taiwan Diagnostic Subsidiary March 19th, 2015
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Graphenea embarks on a new era April 16th, 2015